Differences in Lipid Profile Findings in HAART Naive vs. HAART Treated HIV Positive Patients

Main Article Content

E Aghimien
F Okhimamhe

Abstract

This study was to assess the lipid profile changes present in HIV positive HAART treated vs. HAART Naive patients. Data was obtained from seventy six patients each in three groups (HAART treated, HAART Naive and Controls) who met the inclusion criteria after written informed consent was obtained. Ethical approval was obtained from the Research and Ethics Committee of the University of Benin Teaching Hospital, Benin City, Nigeria. The mean age for the treatment naïve patients was 41.39 ± 7.23years while HAART treated and normal controls had mean age of 44.01 ± 7.13years and 42.95 ± 9.55years respectively. There were statistically significant differences in most anthropometric measurements of patients in all three groups. Also, Obesity was present in 7.9% of HAART treated and 6.6% of HAART naive patients. Abnormal waist circumference was also noted in 65.8% of patients in both HIV positive patient groups while an abnormal waist-hip ratio was present in 43.4% and 48.7% of HAART treated and HAART naive patients respectively. Elevated total cholesterol and abnormalities in the HDL levels were the most prevalent abnormal lipid profile parameters. This study showed derangements in anthropometric and lipid profile parameters in HIV positive patients compared to controls with alterations in total cholesterol levels in HAART treated patients. These effects are possibly indicative of HAART's impact on lipid metabolism through multi-factorial mechanisms which would need to be elucidated by further studies.

Metrics

Metrics Loading ...

Article Details

How to Cite
1.
Aghimien E, Okhimamhe F. Differences in Lipid Profile Findings in HAART Naive vs. HAART Treated HIV Positive Patients. Wes J Med Biomed Sci [Internet]. 2021 Aug. 23 [cited 2024 Oct. 31];2(2):113-9. Available from: https://www.wjmbs.com.ng/index.php/wjmbs/article/view/47
Section
Original Article
Author Biography

E Aghimien, University of Benin Teaching Hospital, Benin city, Nigeria

Consultant Cardiologist,

University of Benin Teaching Hospital,

Benin City, Nigeria.

References

Thienemann F, Sliwa K, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: a global perspective. Eur Heart J. 2013;34(46):3538-46.

Sachdeva S, Kaur S, Khurana T, Singh G. A Study of Cardiac Manifestations of HIV/AIDS. Ann Int Med Dent Res. 2017;3(3):18-21.

HIV/AIDS JUNPo, HIV/AIDS JUNPo. Global AIDS update 2016. Available from http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-2016_en.pdf accessed as at 25th June 2019.

Bhardwaj A, Parikh R, Daoko J, Singh L, Shamoon F, Bhardwaj A, et al. Cardiovascular Manifestation of HIV: Review. J Antivir Antiretrovir. 2009;1(1):11-6.

Sadigh M, Puttagunta S. Cardiac manifestations of HIV. Front Biosci. 2003;8:s305-s13.

Cotter BR. Epidemiology of HIV cardiac disease. Prog Cardiovasc Dis. 2003;45(4):319-26.

Sani MU, Okeahialam BN, Aliyu SH, Enoch DA. Human immunodeficiency virus (HIV) related heart disease: a review. Wien Klin Wochenschr. 2005;117(3):73-81.

Dillion DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja NB, et al. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: A Systematic Review And Meta-Analysis. Int J Epidemiol 2013;42(6):1754-71.

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.

Sharifah HS. Gender and HIV/AIDS. The human rights and security perspectives. [online], [3screens]. Accessed 2020 Mar 10. Available from: https://www.un.org/womenwatch/daw/csw/Shahabudin2001.htm

UNICEF Education Section. HIV /AIDS Education: A Gender Perspective; Tips and Tools. United Nations Children’s Fund Programme Division. New York; USA. 2002:1-21.[Accessed 2020 Mar 13].Available from: https://www.unicef.org/lifeskills/index_8657.html

Mulligan K, Parker RA, Komarow L, Grinspoon KS, Tebas P, Robbins KG, et al. Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial. J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):590–597.

Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D, et al. Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr. 2005;40(2):121–131.

Muhammad S, Sani Mahmoud U, Okeahialam B.N. Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Niger Med J 2013;54(3): 185-190

Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS 2003;17:1179-93.

Jerico C, Knobel H, Montero M, Ordoñez-Llanos J, Guelar A, Gimeno JL, et al. Metabolic syndrome among HIV-infected patients: Prevalence, characteristics, and related factors. Diabetes Care 2005;28:132-7.

Masia M, Padilla S, Bernal E. Influence of anti retroviral therapy on oxidative stress and cardiovascular risk. A prospective cross sectional study in HIV - infected patients. Clin Ther. 2007;29:1448–1455.

Adewole OO, Eze S, Betiku Y, Anteyi E, Wada I, Ajuwon Z, et al. Lipid profile in HIV/AIDS patients in Nigeria. Afr Health Sci. 2010;10(2):144–149.

Akpa MR, Agomoah D, Alasia DD. Lipid profile of healthy adult Nigerians in Port Harcourt, Nigeria. Niger J Med. 2006;2:137–140.